Market Cap 160.27M
Revenue (ttm) 28.70M
Net Income (ttm) -66.95M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -233.28%
Debt to Equity Ratio 0.00
Volume 7,014,311
Avg Vol 4,629,920
Day's Range N/A - N/A
Shares Out 228.31M
Stochastic %K 81%
Beta 1.25
Analysts Strong Sell
Price Target $4.67

Company Profile

Vaxart, Inc., a clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its vector-adjuvant-antigen standardized technology proprietary oral vaccine platform in the United States. The company's product pipeline includes norovirus vaccine, a bivalent oral tablet vaccine in Phase 2 clinical trial for the GI.1 and GII.4 norovirus strains; coronavirus vaccine, which is in Phase 2 clinical trial, for the treatment of SARS-CoV-2 infection; seasonal influ...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 550 3500
Fax: 650 871 8580
Website: vaxart.com
Address:
170 Harbor Way, Suite 300, South San Francisco, United States
Terry_CA3
Terry_CA3 Jun. 16 at 7:55 PM
0 · Reply
Mucosal_Immunity
Mucosal_Immunity Jun. 16 at 7:55 PM
$VXRT Not for sale!!
0 · Reply
DOC1977
DOC1977 Jun. 16 at 7:52 PM
$VXRT ah news and we r off to the races !!!!
1 · Reply
WEN_PLUTO_BONES
WEN_PLUTO_BONES Jun. 16 at 7:51 PM
$VXRT $500M government contract with all kinds of positive news coming out. Yeah Okay.. I’ll send all the shorts a gift card for roadside hotdogs when we’re eating king crab legs and get our feet massaged.
1 · Reply
Chrissytina
Chrissytina Jun. 16 at 7:50 PM
$VXRT These games are being played before the split…Wake up & smell the coffee folks, deal with it!
1 · Reply
Twinfin
Twinfin Jun. 16 at 7:49 PM
$VXRT they dont care about compliance
3 · Reply
Aratcountry
Aratcountry Jun. 16 at 7:48 PM
$VXRT everyone knew the criminals would attack with their synthetics, that doesn’t piss me off. What does is there was no help from management or BOD today, it was primed.
1 · Reply
Terry_CA3
Terry_CA3 Jun. 16 at 7:48 PM
$VXRT my entire
1 · Reply
investing_by_fomo
investing_by_fomo Jun. 16 at 7:43 PM
$VXRT fucking hell didn't this guy say he will be leaving from posting on here? Yet here he is again like the parasite he is yes, it's clear we are going to OTC now, so sell your shares then, your constant bitching on this platform doesn't benefit anyone
1 · Reply
maxbeck
maxbeck Jun. 16 at 7:42 PM
$VXRT Does anyone seriously believe that Big Pharma would let the opportunity slip away to acquire a company with products like the Noro treatment and the Covid pill? It’s Lo and Finney who won’t even pick up the phone and are doing everything they can to enrich themselves through reverse splits and dilutions. These are gangsters and crooks.
1 · Reply
Latest News on VXRT
Vaxart, Inc. (VXRT) Q1 2025 Earnings Call Transcript

May 13, 2025, 8:43 PM EDT - 4 weeks ago

Vaxart, Inc. (VXRT) Q1 2025 Earnings Call Transcript


Vaxart Appoints Jeroen Grasman as Chief Financial Officer

May 13, 2025, 4:01 PM EDT - 4 weeks ago

Vaxart Appoints Jeroen Grasman as Chief Financial Officer


Vaxart, Inc. (VXRT) Q4 2024 Earnings Call Transcript

Mar 20, 2025, 6:25 PM EDT - 3 months ago

Vaxart, Inc. (VXRT) Q4 2024 Earnings Call Transcript


Vaxart, Inc. (VXRT) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 6:19 PM EST - 7 months ago

Vaxart, Inc. (VXRT) Q3 2024 Earnings Call Transcript


Vaxart, Inc. (VXRT) Q2 2024 Earnings Call Transcript

Aug 8, 2024, 8:51 PM EDT - 11 months ago

Vaxart, Inc. (VXRT) Q2 2024 Earnings Call Transcript


Vaxart Provides Business Update

Jun 17, 2024, 4:05 PM EDT - 1 year ago

Vaxart Provides Business Update


Vaxart, Inc. (VXRT) Q1 2024 Earnings Call Transcript

May 13, 2024, 5:49 PM EDT - 1 year ago

Vaxart, Inc. (VXRT) Q1 2024 Earnings Call Transcript


Vaxart, Inc. (VXRT) Q4 2023 Earnings Call Transcript

Mar 14, 2024, 7:03 PM EDT - 1 year ago

Vaxart, Inc. (VXRT) Q4 2023 Earnings Call Transcript


Vaxart, Inc. Announces Management Change

Jan 16, 2024, 9:22 AM EST - 1 year ago

Vaxart, Inc. Announces Management Change


Terry_CA3
Terry_CA3 Jun. 16 at 7:55 PM
0 · Reply
Mucosal_Immunity
Mucosal_Immunity Jun. 16 at 7:55 PM
$VXRT Not for sale!!
0 · Reply
DOC1977
DOC1977 Jun. 16 at 7:52 PM
$VXRT ah news and we r off to the races !!!!
1 · Reply
WEN_PLUTO_BONES
WEN_PLUTO_BONES Jun. 16 at 7:51 PM
$VXRT $500M government contract with all kinds of positive news coming out. Yeah Okay.. I’ll send all the shorts a gift card for roadside hotdogs when we’re eating king crab legs and get our feet massaged.
1 · Reply
Chrissytina
Chrissytina Jun. 16 at 7:50 PM
$VXRT These games are being played before the split…Wake up & smell the coffee folks, deal with it!
1 · Reply
Twinfin
Twinfin Jun. 16 at 7:49 PM
$VXRT they dont care about compliance
3 · Reply
Aratcountry
Aratcountry Jun. 16 at 7:48 PM
$VXRT everyone knew the criminals would attack with their synthetics, that doesn’t piss me off. What does is there was no help from management or BOD today, it was primed.
1 · Reply
Terry_CA3
Terry_CA3 Jun. 16 at 7:48 PM
$VXRT my entire
1 · Reply
investing_by_fomo
investing_by_fomo Jun. 16 at 7:43 PM
$VXRT fucking hell didn't this guy say he will be leaving from posting on here? Yet here he is again like the parasite he is yes, it's clear we are going to OTC now, so sell your shares then, your constant bitching on this platform doesn't benefit anyone
1 · Reply
maxbeck
maxbeck Jun. 16 at 7:42 PM
$VXRT Does anyone seriously believe that Big Pharma would let the opportunity slip away to acquire a company with products like the Noro treatment and the Covid pill? It’s Lo and Finney who won’t even pick up the phone and are doing everything they can to enrich themselves through reverse splits and dilutions. These are gangsters and crooks.
1 · Reply
investing_by_fomo
investing_by_fomo Jun. 16 at 7:39 PM
$VXRT fucking hell without any leg up from the already useless board this stock will just drop lower until after delisting The only thing Low can do now for the investors is resign and even that he is incapable of doing
0 · Reply
maxbeck
maxbeck Jun. 16 at 7:38 PM
$VXRT The Vaast platform is functioning and has been confirmed. A remedy against Noro is as good as certain—emergency approval may even come in the near future. The Covid pill is also confirmed and, in my opinion, with 10,000 participants, it's just a formality. It's not even a Phase 2b trial, but will go straight into Phase 3, and here as well, emergency approval is expected. The biggest problem is the management with Lo and Finney, who are doing everything they can to sabotage the progress.
0 · Reply
WEN_PLUTO_BONES
WEN_PLUTO_BONES Jun. 16 at 7:37 PM
$VXRT NOT FOR SALE
1 · Reply
Terry_CA3
Terry_CA3 Jun. 16 at 7:36 PM
0 · Reply
franklin2025
franklin2025 Jun. 16 at 7:36 PM
$VXRT SHORTS ARE RUNNING OUT OF AMMO
0 · Reply
Vax87
Vax87 Jun. 16 at 7:35 PM
$VXRT MM has pushed this stock down over .25c today, considering the drops, alone. How is this even allowed? How is this artificially, even further, being held up from squeezing? The MM is the epicenter of the problem.
1 · Reply
maxbeck
maxbeck Jun. 16 at 7:34 PM
$VXRT $1.78 to $2.5 Short Term and $14 to $16 the next 6 months.... this is my prediction ..chart looks good...but you never know here..
1 · Reply
BrutisWalter
BrutisWalter Jun. 16 at 7:30 PM
$VXRT Extension will be approved for the same amount of time we lost with the Stop Work Order.IMHO
1 · Reply
Shonstar
Shonstar Jun. 16 at 7:29 PM
$VXRT Unfortunately the stock market is dead, way too much blatent naked shorting has destroyed it and now it’s just a legal fraud system to steal and bankrupt companies.
0 · Reply
franklin2025
franklin2025 Jun. 16 at 7:29 PM
$VXRT RELAX PEOPLE, JUST KEEP ACCUMULATING SHARES
0 · Reply
EaE
EaE Jun. 16 at 7:28 PM
$VXRT Partnership deal in next ten days pushing us well over a dollar then appeal. We can hope!
0 · Reply
Harpua97
Harpua97 Jun. 16 at 7:26 PM
$VXRT OTC? You guys know my feelings on OTC and the damage I think it would do to retail. The people have spoken on the r/s alternative, so what comes next? Looks like it’s going to come down to whether or not we receive an extension from Nasdaq… REASONS WE MAY GET AN EXTENSION: - Trial pause by government created an unusual circumstance outside of the company’s control and materially impacted the share price. - Resumption of trial and up to $460MM of funding indicates strong belief in the promise of the company, now affirmed by both sides of the political aisle. - Excellent Noro P1 results point to a potentially bright future, especially as Vaxart seeks to quickly jump to P2 before end of year (hopefully). - Ongoing 10k person covid trial having a chance to play out could materially impact share price. - Potential partnership looming, with extremely bullish sentiment from management about getting a partnership done soon. (More than previous partnership mentions). - Strong share price action showing an upward trend. REASONS WE MAY NOT GET AN EXTENSION: - Receiving a third extension is exceedingly rare, and we aren’t quite sure what Nasdaq would need to see in order to allow it. - Shareholders have made their voices heard that they will not support a reverse split. This works against us for extension purposes, as Nasdaq prefers to see an r/s as a backup solution in the event that compliance isn’t reached, even just for a first or second extension. - We are still needing to rise by ~40% to achieve compliance, so it’s not like we’re right at the doorstep of it. BOTTOM LINE: This one is just too close to call. I believe that if either (a) a partnership is announced before 6/30; or (b) we get over $1 before 6/30 (even though it won’t be enough time to do 10 consecutive trading days), then we are more likely than not to get the extension. However if neither of those happens, I’m a lot less confident. What do you guys think?
2 · Reply